Reply

Journal of the American Academy of Dermatology

Volumn 22, Issue 3, 1990, Pages 535-536

  Woodley, David T ^a   Crow, Laura ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN DERIVATIVE;

ADULT; BIOLOGICAL MODEL; CASE REPORT; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; LETTER; MALE; METHODOLOGY; PEMPHIGOID; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; EPIDERMOLYSIS BULLOSA; NOTE;

ADULT; CASE REPORT; CYCLOSPORINS; EPIDERMOLYSIS BULLOSA; FEMALE; HUMAN;

EID: 85025527374     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(08)80405-7     Document Type: Letter

References (10)

1. Treatment of epidermolysis bullosa acquisita with cyclosporine [Letter]
2. Effects of cyclosporine on bullous pemphigoid and pemphigus [Letter]
3. Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita
4. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin
5. The epidermolysis bullosa acquisita antigen is type VII procollagen
6. Cyclosporine A
7. Inhibition of T-cell activity by cyclosporine A
8. Cyclosporine A mediates immunosuppression of cytotoxic T-cell responses while impairing the release of IL-1 and IL-2
9. Selective effects of cyclosporine A on functional B cell subsets in the mouse
10. Cyclosporine-associated chronic nephropathy